168 related articles for article (PubMed ID: 36428867)
1. The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMD.
Faatz H; Rothaus K; Ziegler M; Book M; Spital G; Lange C; Lommatzsch A
Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36428867
[TBL] [Abstract][Full Text] [Related]
2. Correlation of retinal alterations with vascular structure of macular neovascularisation in swept-source optical coherence tomography angiography in age-related macular degeneration.
Faatz H; Rothaus K; Ziegler M; Book M; Spital G; Heimes-Bussmann B; Pauleikhoff D; Lommatzsch A
Int Ophthalmol; 2022 May; 42(5):1553-1562. PubMed ID: 35028773
[TBL] [Abstract][Full Text] [Related]
3. Vascular Analysis of Type 1, 2, and 3 Macular Neovascularization in Age-Related Macular Degeneration Using Swept-Source Optical Coherence Tomography Angiography Shows New Insights into Differences of Pathologic Vasculature and May Lead to a More Personalized Understanding.
Faatz H; Rothaus K; Ziegler M; Book M; Heimes-Bussmann B; Pauleikhoff D; Lommatzsch A
Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327496
[TBL] [Abstract][Full Text] [Related]
4. OCTA Biomarker Search in Patients with nAMD: Influence of Retinal Fluid on Time-Dependent Biomarker Response.
Told R; Reumueller A; Schranz M; Brugger J; Weigert G; Reiter GS; Sacu S; Schmidt-Erfurth U
Curr Eye Res; 2023 Jun; 48(6):600-604. PubMed ID: 36891909
[TBL] [Abstract][Full Text] [Related]
5. Correlation of vascular and fluid-related parameters in neovascular age-related macular degeneration using deep learning.
Schranz M; Told R; Hacker V; Reiter GS; Reumueller A; Vogl WD; Bogunovic H; Sacu S; Schmidt-Erfurth U; Roberts PK
Acta Ophthalmol; 2023 Feb; 101(1):e95-e105. PubMed ID: 35912717
[TBL] [Abstract][Full Text] [Related]
6. EFFECT OF RANIBIZUMAB AND AFLIBERCEPT ON RETINAL PIGMENT EPITHELIAL DETACHEMENT, SUBRETINAL AND INTRARETINAL FLUID IN AGE-RELATED MACULAR DEGENERATION.
Sumarová P; Ovesná P; Matušková V; Beránek J; Michalec M; Michalcová L; Autrata D; Vysloužilová D; Chrapek O
Cesk Slov Oftalmol; 2022; 78(4):176-185. PubMed ID: 35922146
[TBL] [Abstract][Full Text] [Related]
7. Development of Intraretinal Fluid in Neovascular Age-Related Macular Degeneration During Anti-Vascular Endothelial Growth Factor Treatment.
Cho HJ; Yoon W; Yoon J; Na SK; Lee J; Kim J; Kim CG; Kim JW
Am J Ophthalmol; 2022 Feb; 234():6-14. PubMed ID: 34339661
[TBL] [Abstract][Full Text] [Related]
8. Analyses of the effects of persistent subretinal fluid on visual/anatomic outcomes according to the type of macular neovascularization during the relaxed treat-and-extend protocol in age-related macular degeneration patients.
Kim KT; Chae JB; Lee S; Seo EJ; Kim DY
BMC Ophthalmol; 2021 Aug; 21(1):294. PubMed ID: 34376158
[TBL] [Abstract][Full Text] [Related]
9. Imaging Biomarkers of 1-Year Activity in Type 1 Macular Neovascularization.
Costanzo E; Parravano M; Giannini D; Borrelli E; Sacconi R; Querques G
Transl Vis Sci Technol; 2021 May; 10(6):18. PubMed ID: 34111264
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Optical Coherence Tomography Angiography Parameters in Type 1 Macular Neovascularization Secondary to Age-Related Macular Degeneration.
Arrigo A; Aragona E; Di Nunzio C; Bandello F; Parodi MB
Transl Vis Sci Technol; 2020 Aug; 9(9):48. PubMed ID: 32934898
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and visual outcomes of non-resolving subretinal fluid in neovascular AMD despite continuous monthly anti-VEGF injections: a long-term follow-up.
Hosseini H; Rabina G; Pettenkofer M; Au A; Chehaibou I; Heilweil G; Weiner AJ; Ip M; Loewenstein A; Schwartz SD
Graefes Arch Clin Exp Ophthalmol; 2021 May; 259(5):1153-1160. PubMed ID: 33245430
[TBL] [Abstract][Full Text] [Related]
12. Identification of macular neovascularization in central serous chorioretinopathy using swept-source OCT angiography.
Staropoli PC; Iyer P; Gregori G; Rosenfeld PJ; Flynn HW
Am J Ophthalmol Case Rep; 2023 Jun; 30():101843. PubMed ID: 37092114
[TBL] [Abstract][Full Text] [Related]
13. OCT-Derived Radiomic Features Predict Anti-VEGF Response and Durability in Neovascular Age-Related Macular Degeneration.
Kar SS; Cetin H; Lunasco L; Le TK; Zahid R; Meng X; Srivastava SK; Madabhushi A; Ehlers JP
Ophthalmol Sci; 2022 Dec; 2(4):100171. PubMed ID: 36531588
[TBL] [Abstract][Full Text] [Related]
14. Fluid dynamics between injections in incomplete anti-VEGF responders within neovascular age-related macular degeneration: a prospective observational study.
Gigon A; Iskandar A; Eandi CM; Mantel I
Int J Retina Vitreous; 2022 Mar; 8(1):19. PubMed ID: 35260186
[TBL] [Abstract][Full Text] [Related]
15. Neovascular age-related macular degeneration in which exudation predominantly occurs as a subretinal fluid during anti-vascular endothelial growth factor treatment.
Cho HJ; Song MY; Yoon W; Yoon J; Na SK; Lee J; Kim J; Kim JW
Sci Rep; 2022 Feb; 12(1):3167. PubMed ID: 35210516
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Comparison of the Vascular Structure of Macular Neovascularizations Between Swept-Source and Spectral-Domain Optical Coherence Tomography Angiography.
Faatz H; Rothaus K; Ziegler M; Book M; Lommatzsch C; Spital G; Gutfleisch M; Pauleikhoff D; Lommatzsch A
Clin Ophthalmol; 2020; 14():3179-3186. PubMed ID: 33116368
[TBL] [Abstract][Full Text] [Related]
17. The long-term effects of anti-vascular endothelial growth factor therapy on the optical coherence tomography angiographic appearance of neovascularization in age-related macular degeneration.
Levine ES; Custo Greig E; Mendonça LSM; Gulati S; Despotovic IN; Alibhai AY; Moult E; Muakkassa N; Quaranta-El Maftouhi M; El Maftouhi A; Chakravarthy U; Fujimoto JG; Baumal CR; Witkin AJ; Duker JS; Hartnett ME; Waheed NK
Int J Retina Vitreous; 2020; 6():39. PubMed ID: 32844038
[TBL] [Abstract][Full Text] [Related]
18. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
[TBL] [Abstract][Full Text] [Related]
19. [Antiangiogenic therapy for types I and II macular neovascularization in age-related macular degeneration].
Budzinskaya MV; Shelankova AV; Andreeva AA; Plyukhova AA; Afanasyeva MA
Vestn Oftalmol; 2021; 137(5):7-13. PubMed ID: 34726852
[TBL] [Abstract][Full Text] [Related]
20. Non-neovascular age-related macular degeneration with subretinal fluid.
Hilely A; Au A; Freund KB; Loewenstein A; Souied EH; Zur D; Sacconi R; Borrelli E; Peiretti E; Iovino C; Sugiura Y; Ellabban AA; Monés J; Waheed NK; Ozdek S; Yalinbas D; Thiele S; de Moura Mendonça LS; Lee MY; Lee WK; Turcotte P; Capuano V; Filali Ansary M; Chakravarthy U; Lommatzsch A; Gunnemann F; Pauleikhoff D; Ip MS; Querques G; Holz FG; Spaide RF; Sadda S; Sarraf D
Br J Ophthalmol; 2021 Oct; 105(10):1415-1420. PubMed ID: 32920528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
